FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

SALIX PHARMACEUTICALS LTD: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2012-01-01 – 2012-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/83094262-8b7f-4d87-8a8a-d6b75933d5fd

Reported value

$391.947M{"amount": 391947000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
SALIX PHARMACEUTICALS LTD
Metric
cashflow_financing
Period
2012-01-01 – 2012-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-12-218601 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T09:47:53.530254+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001009356/cashflow-financing/2012-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.